Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006

Vibeke Strand, Michelle Petri, Kenneth Kalunian, Caroline Gordon, Daniel J Wallace, Kathryn Hobbs, Lexy Kelley, Brian Kilgallen, William A Wegener, David M Goldenberg

Research output: Contribution to journal › Article › peer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006'. Together they form a unique fingerprint.

Medicine & Life Sciences